Table 2.

Tumour RECIST response rates at 8 and 16 weeks.

	Target cancer site	All		Ovarian cancer		Breast cancer
Timepoint	Response	N = 67		N = 57		N = 10
		No.	%	No.	%	No.	%
8 weeks	CBR (CR, PR and SD)	22	33	17	30	5	50
	CR	0	0	0	0	0	0
	PR	1	1	0	0	1	10
	SD	21	31	17	30	4	40
	PD	22	33	18	32	4	40
	Withdrew prior to scan	23	34	22	39	1	10
16 weeks	Objective response (CR, PR and SD)	12	18	8	14	4	40
	CR	0	0	0	0	0	0
	PR	0	0	0	0	0	0
	SD	12	18	8	14	4	40
	PD	6	9	5	9	1	10
	Withdrew prior to scan	49	73	44	77	5	50

CBR clinical benefit rate, CR complete response, PR partial response, SD stable disease, PD progressive disease